Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 426,301 shares at $96.48 ($42.4M) on 2019-08-12, disclosed to the SEC on 2019-08-14.
Open-market sale of $42.4M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.48 | 5,309 | $512K | 1.2% |
| 2 | $97.61 | 17,105 | $1.7M | 3.9% |
| 3 | $98.64 | 45,010 | $4.4M | 10.5% |
| 4 | $99.58 | 51,254 | $5.1M | 12.0% |
| 5 | $100.29 | 273 | $27K | 0.1% |
| 6 | $101.19 | 140 |
| $14K |
| 0.0% |
| 7 | $96.79 | 2,400 | $232K | 0.5% |
| 8 | $97.83 | 11,813 | $1.2M | 2.7% |
| 9 | $98.96 | 44,446 | $4.4M | 10.4% |
| 10 | $99.83 | 158,529 | $15.8M | 37.3% |
| 11 | $100.75 | 89,416 | $9.0M | 21.2% |
| 12 | $101.30 | 606 | $61K | 0.1% |
| Total | $99.58 avg | 426,301 | $42.4M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |